Atlas Trials

Effect of Risedronate on Bone Morbidity in Fibrous Dysplasia of Bone

Clinical trial NCT00445575 · COMPLETED

Trial details

NCT number
NCT00445575
Sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Fibrous Dysplasia of Bone
Start date
2007-07-22
Primary completion
2017-12-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.